Range
37.16 - 38.64
Vol / Avg.
416.1K/731.8K
Div / Yield
-
52 Wk
16.5 - 38.22
Mkt Cap
2.9B
Payout Ratio
-
Open
37.6
P/E
-
EPS
-0.39
Shares
76.9M
Outstanding
76.9M
Total Float
73.7M
load more
Sector: Health Care.Industry: Biotechnology
Dicerna Pharmaceuticals Inc is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.370-0.390 -0.0200
REV46.280M47.603M1.323M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DRNADicerna Pharmaceuticals3.35%2.9B

Dicerna Pharmaceuticals Frequently Asked Questions

Q

How do I buy Dicerna Pharmaceuticals (DRNA) stock?

A

You can purchase shares of Dicerna Pharmaceuticals (NASDAQ: DRNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Dicerna Pharmaceuticals's (DRNA) competitors?

Q

What is the target price for Dicerna Pharmaceuticals (DRNA) stock?

A

The latest price target for Dicerna Pharmaceuticals (NASDAQ: DRNA) was reported by HC Wainwright & Co. on June 23, 2021. The analyst firm set a price target for 42.00 expecting DRNA to rise to within 12 months (a possible 9.72% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Dicerna Pharmaceuticals (DRNA)?

A

The stock price for Dicerna Pharmaceuticals (NASDAQ: DRNA) is $38.28 last updated Thu Jun 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Dicerna Pharmaceuticals (DRNA) pay a dividend?

A

There are no upcoming dividends for Dicerna Pharmaceuticals.

Q

When is Dicerna Pharmaceuticals (NASDAQ:DRNA) reporting earnings?

A
Dicerna Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Dicerna Pharmaceuticals (DRNA) going to split?

A

There is no upcoming split for Dicerna Pharmaceuticals.

Q

What sector and industry does Dicerna Pharmaceuticals (DRNA) operate in?

A

Dicerna Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.